Blog Band - Page 272 of 299

29

Jun 2021

PharmaShots Interview: Medicago’s Nathalie Landry Shares Insights on the Phase 2 Results of Plant-Based COVID-19 Vaccine

In an Interview with PharmaShots, Nathalie Landry, Executive Vice President, Scientific, and Medical Affairs at Medicago share her views on the P-II results of adjuvanted plant-based COVID-19 vaccine. Shots: The P-II study…

28

Jun 2021

VIEWPOINTS

PharmaShots Interview: Eli Lilly’s Kevin Cammack Shares Insights on Lilly’s Collaboration with Global Diabetes Technology Companies

In an interview with PharmaShots, Kevin Cammack, Head of Connected Care, Eli Lilly and Company shares insights on the Lilly alliance with DexCom, Glooko, myDiabby Healthcare, and Roche to provide compatibility between…

24

Jun 2021

THOUGHTSPOT

Nutraceuticals Under Evaluation for COVID-19 Prevention and Treatment

The pandemic has led to the identification of some promising nutraceuticals for the management and prevention of Covid-19. Nutraceuticals with their immune-boosting potential can amplify the body's defense system against…

22

Jun 2021

VIEWPOINTS

PharmaShots Interview: Impact of new regulations and trends in the medical device industry in India – interviews of Dr. Bina Naik and Dr. Ashish Indani during DIA Medical Device Conference 20

The Medical Devices Conference was hosted by DIA India on 21st and 22nd February in collaboration with the Medical Technology Association of India (MTaI), AIC-AMTZ Medivalley Incubation Council and mDI…

22

Jun 2021

VIEWPOINTS

PharmaShots Interview: Myriad Genetics’ Thomas Slavin Shares Insights on the Data Validating Breast Cancer PRS Across Ancestries

In an interview with PharmaShots, Dr. Thomas Slavin, M.D, Senior Vice President of Medical Affairs, Oncology at Myriad Genetics and study co-author shared his views on the data presented at ASCO 2021…

22

Jun 2021

VIEWPOINTS

PharmaShots Interview: Synthego’s Dr. Bob Deans Shares Insights on the Launch of its Eclipse Platform for Drug Discovery

In an interview with PharmaShots, Dr. Bob Deans, Chief Scientific Officer at Synthego shares insights on the wide availability of its new CRISPR-based platform, Eclipse. Synthego created the Eclipse platform to enhance…

21

Jun 2021

VIEWPOINTS

PharmaShots Interview: Janssen’s Nan Li Shares Insights on the Data Presented at ISPOR 2021

In an interview with PharmaShots, Nan Li, Director of Access, Janssen Retina DAS shared her views on the attempts to quantify the economic burden of X-linked retinitis pigmentosa and achromatopsia. Shots: Janssen…

17

Jun 2021

INSIGHTS+

Insights+: The US FDA New Drug Approvals in May 2021

The US FDA has approved 4 NDAs and 1 BLAs in 2021, leading to treatments for patients and advances in the health care industry. The Center for Drug Evaluation and…

15

Jun 2021

EVENTS

4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress

Event description: Our 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress-US Edition to be held on 28th June - 1st July 2021 would address the challenges and future directions in IO research. The…

15

Jun 2021

VIEWPOINTS

PharmaShots Interview: n-Lorem Foundation’s Dr. Stanley T. Crooke Shares Insights on its Collaboration with Ultragenyx to Provide Personalized Medicines to Ultra-Rare Patients

In an interview with PharmaShots, Dr. Stanley T. Crooke, Founder, and Chief Executive Officer and Chairman of the Board at n-Lorem Foundation share his views on the collaboration with Ultragenyx. Shots: n-Lorem Foundation…

PharmaShots Interview: Medicago’s Nathalie Landry Shares Insights on the Phase 2 Results of Plant-Based COVID-19 Vaccine

PharmaShots Interview: Eli Lilly’s Kevin Cammack Shares Insights on Lilly’s Collaboration with Global Diabetes Technology Companies

Nutraceuticals Under Evaluation for COVID-19 Prevention and Treatment

PharmaShots Interview: Impact of new regulations and trends in the medical device industry in India – interviews of Dr. Bina Naik and Dr. Ashish Indani during DIA Medical Device Conference 20

PharmaShots Interview: Myriad Genetics’ Thomas Slavin Shares Insights on the Data Validating Breast Cancer PRS Across Ancestries

PharmaShots Interview: Synthego’s Dr. Bob Deans Shares Insights on the Launch of its Eclipse Platform for Drug Discovery

PharmaShots Interview: Janssen’s Nan Li Shares Insights on the Data Presented at ISPOR 2021

Insights+: The US FDA New Drug Approvals in May 2021

4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress

PharmaShots Interview: n-Lorem Foundation’s Dr. Stanley T. Crooke Shares Insights on its Collaboration with Ultragenyx to Provide Personalized Medicines to Ultra-Rare Patients

Contact US

OUR INFORMATION

FOLLOW US